AI blood test could replace scalpel for breast cancer staging
NCT ID NCT07304934
First seen Jan 05, 2026 · Last updated May 23, 2026 · Updated 22 times
Summary
This study is testing a new blood test that uses artificial intelligence to analyze DNA fragments in the blood. The goal is to see if it can accurately determine the stage of breast cancer and whether it has spread to lymph nodes, potentially reducing the need for surgery. The study will involve 269 people with newly diagnosed or treated breast cancer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.